Aims & Scope ::: Clinical Cancer Drugs

ISSN: 2212-6988 (Online)
ISSN: 2212-697X (Print)


Volume 4, 2 Issues, 2017


Download PDF Flyer




Clinical Cancer Drugs

This journal supports open access

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Giulio Francia
The University of Texas
El Paso, TX
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Aims & Scope

Clinical Cancer Drugs publishes original research, expert reviews, and thematic issues in all core areas of translational and clinical cancer drug research.

The journal publishes pre-clinical and clinical studies on the development of new anti-cancer agents. Clinical studies of new reported anti-cancer drugs include Phase 1–IV clinical trial studies, their designs, research methodologies, and analyses. The journal is essential reading for clinical oncologists, toxicologists, medicinal chemists, and pharmacologists.

Advertisement

Webmaster Contact: info@benthamscience.org Copyright © 2017 Bentham Science